The set of immune cell signatures identified in Cdh11-deficient mice may represent hallmarks of positive disease prognosis in pancreatic cancer, and maybe other solid tumors such as breast, head and neck and colorectal cancers. This evidence concerns the gene CDH11 and familial pancreatic carcinoma.